Results 301 to 310 of about 178,517 (322)

Synthesis of a Bruton’s Tyrosine Kinase Inhibitor [PDF]

Synfacts, 2021
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

ChemMedChem, 2007
Z. Pan, H. Scheerens, Shyr-Jiann Li, B. Schultz, P. Sprengeler, Leland C. Burrill, Rohan V Mendonca, Michael D. Sweeney, Keana C. K. Scott, P. Grothaus, D. Jeffery, J. Spoerke, L. Honigberg, P. Young, S. Dalrymple, J. Palmer   +15 more
semanticscholar   +1 more source

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Helgi B Schiöth, Misty M Attwood, Stefan Knapp   +2 more
exaly  

Next-Generation Bruton Tyrosine Kinase Inhibitors

Journal of Clinical Oncology, 2020
John C. Byrd, Deborah M. Stephens
openaire   +2 more sources

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Barata, Brian I Rini
exaly  

Kinase drug discovery 20 years after imatinib: progress and future directions

Nature Reviews Drug Discovery, 2021
Darren Cross, Pasi A Jänne, Philip Cohen   +2 more
exaly  

Kinase inhibition in autoimmunity and inflammation

Nature Reviews Drug Discovery, 2021
Ali A Zarrin, Bruno Hochhegger, Katherine Bao   +2 more
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Taofeek K Owonikoko, Fadlo R Khuri   +2 more
exaly  

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Bruton's tyrosine kinase in systemic lupus erythematosus

Joint Bone Spine, 2020
Hsien-Tzung Liao, Hsiang-Yuen Tung, Chang-Youh Tsai, Bor-Luen Chiang, Chia-Li Yu   +4 more
openaire   +3 more sources